Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
182.44
-3.15 (-1.70%)
Mar 3, 2025, 4:00 PM EST - Market closed
Company Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.
The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Inspire Medical Systems, Inc.
| Country | United States |
| Founded | 2007 |
| IPO Date | May 3, 2018 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,246 |
| CEO | Timothy Herbert |
Contact Details
Address: 5500 Wayzata Blvd., Suite 1600 Golden Valley, Minnesota 55416 United States | |
| Phone | (844) 672-4357 |
| Website | inspiresleep.com |
Stock Details
| Ticker Symbol | INSP |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001609550 |
| CUSIP Number | 457730109 |
| ISIN Number | US4577301090 |
| Employer ID | 26-1377674 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Timothy P. Herbert | Founder, Chairman, Chief Executive Officer and President |
| Richard J. Buchholz | Chief Financial Officer |
| Randall A. Ban | Executive Vice President of Patient Access &Therapy Development |
| Carlton W. Weatherby | Chief Strategy and Growth Officer |
| John C. Rondoni | Chief Technology Officer |
| Ezgi Yagci | Vice President of Investor Relations |
| Bryan K. Phillips J.D. | Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary |
| Melissa J. Mann | Chief People Officer |
| Ivan Lubogo | SVice President of Strategic Sales |
| Andreas Henke | Executive Vice President and MD of Europe |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 3, 2025 | 144 | Filing |
| Feb 28, 2025 | 144 | Filing |
| Feb 13, 2025 | 144 | Filing |
| Feb 12, 2025 | SCHEDULE 13G/A | Filing |
| Feb 11, 2025 | 144 | Filing |
| Feb 10, 2025 | 10-K | Annual Report |
| Feb 10, 2025 | 8-K | Current Report |
| Jan 13, 2025 | 8-K | Current Report |
| Jan 7, 2025 | 144 | Filing |
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |